Aspira Women's Health Inc. (AWH)
NASDAQ: AWH · IEX Real-Time Price · USD
3.280
-0.080 (-2.38%)
Apr 25, 2024, 4:30 PM EDT - Market closed
Aspira Women's Health Market Cap
Aspira Women's Health has a market cap or net worth of $40.49 million as of April 26, 2024. Its market cap has decreased by -13.85% in one year.
Market Cap
40.49M
Enterprise Value
40.49M
1-Year Change
-13.85%
Ranking
Category
Stock Price
$3.28
Market Cap Chart
Since October 2, 2000, Aspira Women's Health's market cap has decreased from $896.90M to $40.49M, a decrease of -95.49%. That is a compound annual growth rate of -12.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 40.50M | -3.57% |
Apr 24, 2024 | 42.00M | 0.48% |
Apr 23, 2024 | 41.80M | -3.24% |
Apr 22, 2024 | 43.20M | 0.23% |
Apr 19, 2024 | 43.10M | -1.15% |
Apr 18, 2024 | 43.60M | 1.16% |
Apr 17, 2024 | 43.10M | 1.17% |
Apr 16, 2024 | 42.60M | 1.91% |
Apr 15, 2024 | 41.80M | -1.88% |
Apr 12, 2024 | 42.60M | 7.30% |
Apr 11, 2024 | 39.70M | - |
Apr 10, 2024 | 39.70M | 3.66% |
Apr 9, 2024 | 38.30M | 10.06% |
Apr 8, 2024 | 34.80M | 6.75% |
Apr 5, 2024 | 32.60M | -2.10% |
Apr 4, 2024 | 33.30M | -3.76% |
Apr 3, 2024 | 34.60M | 2.37% |
Apr 2, 2024 | 33.80M | -8.40% |
Apr 1, 2024 | 36.90M | 15.31% |
Mar 28, 2024 | 32.00M | -9.86% |
Mar 27, 2024 | 35.50M | -1.93% |
Mar 26, 2024 | 36.20M | -1.63% |
Mar 25, 2024 | 36.80M | -2.39% |
Mar 22, 2024 | 37.70M | 1.07% |
Mar 21, 2024 | 37.30M | 3.90% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
DarioHealth | 42.69M |
Milestone Scientific | 42.68M |
Carmell Therapeutics | 42.34M |
Bolt Biotherapeutics | 42.32M |
NKGen Biotech | 42.19M |
ReWalk Robotics | 41.55M |
iCAD, Inc. | 41.40M |
SAB Biotherapeutics | 40.22M |